A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- ABBVIE INC.
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
430 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cemic /id# 167782
Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
- Gedyt /id# 243423
Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
- Hospital Provincial del Centenario /id# 170898
Rosario, Santa Fe Province, Argentina
- Sanatorio 9 de Julio /id# 167780
San Miguel de Tucumán, Tucumán Province, Argentina
- Hospital Privado Univesitario /id# 167779
Córdoba, Argentina
- Duplicate_universitaetsklinikum St.Poelten /id# 169048
Sankt Pölten, Lower Austria, Austria
- Medizinische Universitaet Wien /id# 169050
Vienna, State of Vienna, Austria
- Medizinische Universitaet Graz /id# 169053
Graz, Styria, Austria
- Ordensklinikum Linz Gmbh Barmherzige Schwestern /id# 215320
Linz, Upper Austria, Austria
- Landeskrankenhaus Salzburg-Universitätsklinikum Der Pmu (lkh) /id# 200685
Salzburg, Austria
- Cliniques Universitaires de Bruxelles Hopital Erasme /id# 200252
Brussels, Brussels Capital, Belgium
- Ucl Saint-Luc /id# 200039
Woluwe-Saint-Lambert, Brussels Capital, Belgium
- Chu Ucl Namur - Site Godinne /id# 200254
Godinne, Namur, Belgium
- Universitair Ziekenhuis Leuven /id# 170812
Leuven, Vlaams-Brabant, Belgium
- Az-Delta /id# 200040
Roeselare, West-Vlaanderen, Belgium
- Imelda Ziekenhuis /id# 211100
Bonheiden, Belgium
- Chu de Liege /id# 200253
Liège, Belgium
- Groupe Sante Chc - Clinique Du Montlegia /id# 200250
Liège, Belgium
- Instituto Goiano de Gastroenterologia E Endoscopia Digestiva /id# 157679
Goiânia, Goiás, Brazil
- Hospital Nossa Senhora Das Graças /id# 157671
Curitiba, Paraná, Brazil
- Hospital de Clinicas de Porto Alegre /id# 157662
Porto Alegre, Rio Grande do Sul, Brazil
- Upeclin Fmb - Unesp /id# 157690
Botucatu, São Paulo, Brazil
- Hospital Das Clinicas Da Faculdade de Medicina de Ribeirao Preto - Usp /id# 157660
Ribeirão Preto, São Paulo, Brazil
- Faculdade de Medicina Do Abc /id# 163995
Santo André, São Paulo, Brazil
- Kaiser Clinica E Hospital Dia /id# 157680
São José do Rio Preto, São Paulo, Brazil
- Umhat Kaspela Eood /id# 200797
Plovdiv, Bulgaria
- Mhat Hadzhi Dimitar /id# 207945
Sliven, Bulgaria
- Second Mhat Sofia /id# 200799
Sofia, Bulgaria
- Umhat Sveti Ivan Rilski /id# 210797
Sofia, Bulgaria
- Umhat Tsaritsa Joanna - Isul /id# 209977
Sofia, Bulgaria
- University of Calgary /id# 169111
Calgary, Alberta, Canada
- Allen Whey Khye Lim Professional Corporation /id# 169767
Edmonton, Alberta, Canada
- Covenant Health /id# 169114
Edmonton, Alberta, Canada
- Fraser Clinical Trials Inc /id# 169102
New Westminster, British Columbia, Canada
- Percuro Clinical Research, Ltd /id# 169109
Victoria, British Columbia, Canada
- London Health Sciences Center- University Hospital /id# 169103
London, Ontario, Canada
- Scott Shulman Medicine Professional Corporation /id# 169113
North Bay, Ontario, Canada
- Toronto Digestive Disease Asso /id# 169106
Vaughan, Ontario, Canada
- Hotel Dieu de Levis /id# 214378
Lévis, Quebec, Canada
- Ciusss de L'Est de L'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /id# 169108
Montreal, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2018
- Primary completion
- 9 Nov 2022
- Completion
- 11 May 2023
- Last update posted
- 16 Jan 2025
- Registered enrollment
- 1,558
- Registry id
- NCT03398148
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.